Company Overview and News

 
ORI / Old Republic International Corp. null

2018-05-16 sec.gov
May 14, 2018 Dear Old Republic Shareholder, We are writing to urge you to VOTE FOR PROPOSAL #4 on the Old Republic 2018 proxy card, which asks the company to prepare a report on board oversight of climate change. The proposal makes the following request:

 
Jane's April Dividend Income Tracker - Retirement Accounts

2018-05-15 seekingalpha
This is the second month I have officially tracked dividend income (in an article) for Jane's Traditional and Roth IRA Accounts. Her combined dividend income totaled $1,300.03.

 
'Safer' Dividend Champions, Show Positive Annual Returns, And Cash To Cover 25+ Years Of Increasing Dividends

2018-05-10 seekingalpha
Broker target-estimated May Dividend Champion top ten net gains ranged 14.52%-29.26%, from SKT, NFG, PG, KO, ORI, PEP, T, LEG, MO, topped by MDP as compiled 4/30/18 and counted 5/7/18.

 
'Safer' Dividend Champions, Show Positive Annual Returns, & Cash To Cover 25+ Years Of Increasing Dividends

2018-05-10 seekingalpha
Broker target-estimated May Dividend Champion top ten net gains ranged 14.52%-29.26%, from SKT, NFG, PG, KO, ORI, PEP, T, LEG, MO, topped by MDP as compiled 4/30/18 and counted 5/7/18.

 
John And Jane - April Dividend Income Tracker - Taxable Account

2018-05-08 seekingalpha
This is the 6th month I have officially tracked dividend income, and it was slightly below expectations with a total of $619.98 of dividends received.

1
ORI / Old Republic International Corp. PX14A6G

2018-05-07 sec.gov
May 4, 2018 <

3
Tracking Kahn Brothers Portfolio - Q1 2018 Update

2018-05-02 seekingalpha
The portfolio continues to be very concentrated with the top five positions accounting for ~44% of the 13F holdings.

 
40 'Safer' Dividend Achievers Of 104 Per April/May Returns And Cash Flow

2018-05-02 seekingalpha
40 of 102 Dividend Achievers (10 or more years of higher dividends) were tagged "safer" because they showed positive annual-returns, and free cash-flow yields greater than dividend yields 4/29/18.

 
ORI / Old Republic International Corp. DEF 14A

2018-04-17 sec.gov
Document SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the

 
If I Had To Build An Income Portfolio Today - Update 28

2018-04-09 seekingalpha
This article is Update 28 to my original article entitled "If I Had to Build An Income Portfolio Today."

 
John And Jane - March Dividend Income Tracker - Taxable Account

2018-04-03 seekingalpha
This is the 5th month I have officially tracked dividend income and it was slightly above expectations with a total of $929.59 of dividends received.

 
ORI / Old Republic International Corp. S-3ASR

2018-03-14 sec.gov
Document As filed with the Securities and Exchange Commission on March 14, 2018

Related Articles

HRTX : Heron Therapeutics Analysis and Research Report

2018-05-25 - Asif

Overview Heron is a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments that address some of the most important unmet patient needs. Heron Therapeutics is developing novel, patient-focused solutions that apply its innovative science and technologies to already approved pharmacological agents for patients suffering from cancer or pain. On August 9, 2016, its first commercial product, SUSTOL, was approved by the FDA. The company developed SUSTOL for the prevention of chemotherapy-induced nausea and vomiting (“CINV”). SUSTOL is indicated, in combination with other antiemetics, in adults for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of moderately emetogenic chemotherapy (“MEC”) or anthracycline and cyclophosphamide (“AC”) combination chemotherapy regimens. The company commenced commercial sales of SUSTOL in the U.S. in October 2016. On November 9, 2017...

ACIA: Acacia Communications Analysis and Research Report

2018-05-25 - Asif

Overview The company's mission is to deliver high-speed coherent optical interconnect products that transform communications networks, relied upon by cloud infrastructure operators and content and communication service providers, through improvements in performance and capacity and reductions in associated costs. By converting optical interconnect technology to a silicon-based technology, a process the company refer to as the siliconization of optical interconnect, the company believe Acacia Communications is leading a disruption that is analogous to the computing industry’s integration of multiple functions into a microprocessor. The company's products include a family of low-power coherent digital signal processor application-specific integrated circuits, or DSP ASICs, and silicon photonic integrated circuits, or silicon PICs, which Acacia Communications has integrated into families of optical interconnect modules with transmission speeds ranging from 100 to 400 gigabits per ...

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

CUSIP: 680223104